PANews, June 19 – According to official sources, Nasdaq-listed company NewGenIVF Group (ticker: NIVF) announced an additional $4 million investment in the prediction market platform K25.ai, completing the company’s $10 million Pre-A funding round at a valuation of $100 million. NewGenIVF Group’s stake is expected to reach 10%. In addition to the equity investment, NewGenIVF Group also holds the exclusive agency rights for K25.ai in the Asia-Pacific region.

K25.ai is an AI-native livestreaming and prediction market platform targeting the Asia-Pacific region. The company has not yet officially launched its product and is currently seeking relevant regulatory approvals in select markets. This investment follows an initial $2 million investment announced in May 2026 and a subsequent $4 million investment announced on June 4, 2026. With the completion of the Pre-A round, K25.ai has initiated its Series A funding round. The company stated that the new funding will be used for product launch, obtaining regulatory licenses in specific Asian markets, and regional expansion.